Description
Semaglutide
Product Overview
Semaglutide is a synthetic Glucagon-Like Peptide-1 (GLP-1) receptor agonist widely studied for its role in glucose metabolism, insulin regulation, appetite control, and body weight management. It mimics the activity of the naturally occurring GLP-1 hormone, helping researchers investigate metabolic pathways involved in type 2 diabetes, obesity, cardiovascular health, and energy balance. Semaglutide is extensively used in metabolic and endocrine research and is intended for laboratory and scientific applications.
Key Features
- Synthetic GLP-1 receptor agonist
- High-purity research-grade peptide
- Studied in metabolic and endocrine research
- Supports investigations of glucose and insulin regulation
- Suitable for laboratory and scientific applications
- Available in multiple research quantities
How It Works
Semaglutide selectively activates GLP-1 receptors, stimulating glucose-dependent insulin secretion while reducing glucagon release. It also slows gastric emptying and influences appetite regulation through central nervous system pathways. Researchers investigate these mechanisms to better understand glucose homeostasis, energy metabolism, obesity, and cardiometabolic health.
Research Applications
Semaglutide is commonly studied in research involving:
- GLP-1 receptor biology
- Type 2 diabetes research
- Obesity and weight management
- Glucose metabolism
- Insulin sensitivity
- Appetite regulation
- Cardiometabolic health
- Energy balance
- Endocrine research
- Metabolic disease studies
Specifications
| Property | Details |
|---|---|
| Product Name | Semaglutide |
| Product Type | GLP-1 Receptor Agonist Peptide |
| Molecular Formula | C187H291N45O59 |
| Molecular Weight | 4113.58 g/mol |
| Research Category | Metabolic & Endocrine Research |
| Appearance | White to off-white lyophilized powder |
Physical Properties
- Appearance: White to off-white lyophilized powder
- Purity: Research Grade
- Solubility: Soluble in sterile water
- Stability: Stable under recommended storage conditions
Storage Instructions
- Store refrigerated at 2–8°C.
- For long-term storage, keep frozen according to manufacturer recommendations.
- Protect from heat, moisture, and direct sunlight.
- Keep the vial tightly sealed.
- Avoid repeated freeze-thaw cycles after reconstitution.
Packaging Information
Available packaging options may include:
- 2 mg Vial
- 5 mg Vial
- 10 mg Vial
- 15 mg Vial
- Multi-vial research kits
- Bulk research quantities
Quality Assurance
Each production batch undergoes strict quality control testing for:
- Identity verification
- Purity analysis
- Peptide integrity
- Stability assessment
- Batch-to-batch consistency
Precautions
- Intended for laboratory research or authorized clinical use where applicable.
- Handle using appropriate laboratory safety procedures.
- Wear suitable personal protective equipment (PPE).
- Store according to the recommended conditions.
- Keep out of reach of unauthorized personnel.
Shelf Life
Shelf life depends on storage conditions and manufacturer specifications. Refer to the product label or Certificate of Analysis (COA) for expiration details and recommended storage requirements.
Frequently Asked Questions (FAQs)
What is Semaglutide?
Semaglutide is a synthetic GLP-1 receptor agonist used in metabolic and endocrine research to investigate glucose regulation, insulin secretion, appetite control, and energy metabolism.
What research areas commonly use Semaglutide?
Researchers commonly study Semaglutide in type 2 diabetes, obesity, glucose metabolism, cardiometabolic health, endocrine function, and weight management research.
How should Semaglutide be stored?
Store refrigerated at 2–8°C and protect it from heat and direct sunlight. Follow the manufacturer’s recommendations for long-term storage and avoid repeated freeze-thaw cycles.
Is a Certificate of Analysis (COA) available?
Most research-grade suppliers provide a Certificate of Analysis (COA) with each production batch to verify identity, purity, and overall product quality.

Reviews
There are no reviews yet.